Kennedy Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-110,748
| Closed | -$8.33M | – | 642 |
|
|
2022
Q2 | $8.33M | Buy |
110,748
+8,106
| +8% | +$610K | 0.23% | 141 |
|
|
2022
Q1 | $2.76M | Buy |
102,642
+80,944
| +373% | +$2.17M | 0.07% | 402 |
|
|
2021
Q4 | $1.04M | Buy |
21,698
+4,487
| +26% | +$214K | 0.02% | 514 |
|
|
2021
Q3 | $1.14M | Buy |
17,211
+1,939
| +13% | +$129K | 0.03% | 512 |
|
|
2021
Q2 | $1.19M | Sell |
15,272
-658
| -4% | -$51.4K | 0.03% | 513 |
|
|
2021
Q1 | $1.51M | Sell |
15,930
-1,525
| -9% | -$144K | 0.03% | 528 |
|
|
2020
Q4 | $2.13M | Sell |
17,455
-174
| -1% | -$21.2K | 0.05% | 500 |
|
|
2020
Q3 | $1.54M | Sell |
17,629
-139
| -0.8% | -$12.1K | 0.04% | 510 |
|
|
2020
Q2 | $1.15M | Buy |
17,768
+122
| +0.7% | +$7.88K | 0.03% | 565 |
|
|
2020
Q1 | $788K | Buy |
17,646
+2,362
| +15% | +$105K | 0.03% | 579 |
|
|
2019
Q4 | $952K | Sell |
15,284
-138
| -0.9% | -$8.6K | 0.02% | 617 |
|
|
2019
Q3 | $580K | Buy |
+15,422
| New | +$580K | 0.01% | 625 |
|